期刊文献+

基因芯片筛选原发性肝癌患者的差异表达基因 被引量:2

Screening differential expression genes of primary hepatocellular carcinoma patients by gene chip technology
下载PDF
导出
摘要 目的利用基因表达谱芯片技术探讨原发性肝癌(PHC)不同阶段(癌组织、癌旁组织、正常组织)差异基因的表达,进一步寻找PHC不同阶段组织中的差异表达基因。方法提取20例肝癌癌组织、癌旁组织和正常组织的总RNA,应用Agilent人类全基因组4×44K基因芯片筛选差异表达基因,采用微阵列类分析(SAS)软件对芯片图像进行分析。结果筛选出癌组织与正常组织差异基因4 175个,其中上调基因1 850个,下调基因2 325个。对筛选出的差异基因进行GO分类,主要分为催化活性、信号转导、酶活性调节、转录活性调节、蛋白运输功能、细胞生长、凋亡等功能过程。结论利用基因芯片技术可高通量地筛选出PHC不同阶段组织的差异表达基因,为进一步阐明PHC的发生机制提供实验依据。 Objective To study the related gene expression in hepatic carcinoma of different stages( cancerous tissue,paraneoplastic tissue,normal tissue) by c DNA expression profiling microarray technique,and to further seek differentially expressed genes of hepatocellular carcinoma tissue in different stages. Methods The whole RNA of 20 cases of cancerous tissue,paraneoplastic tissue,normal tissue of hepatic carcinoma was extracted. Agilent human genome 4 × 44 K gene chip was applied to screen differentially expressed genes,and microarray analysis software( SAS software) was used to analyze chip image. Results 4 175 kinds of differentially expressed genes of cancerous tissue and normal mucosa tissue were screened,among which,there were1 850 kinds of up- regulated genes and 2 325 kinds of down- regulated genes. Then through GO classification,screened differentially expressed genes mainly were divided into the following function and process: catalytic activity,signal transduction,enzymatic activity regulation,transcription activity regulation,protein transportation function,cell growth and apoptosis,and so on.Conclusion Gene chip technology can high- throughput screen differentially expressed genes of hepatocellular carcinoma in different stages,and provide experimental basis for further expounding the occurrence mechanism of hepatocellular carcinoma.
作者 董亚辉 宋展
出处 《河南医学研究》 CAS 2016年第3期393-395,共3页 Henan Medical Research
关键词 肝癌 基因表达谱 基因芯片 hepatic carcinoma gene expression profiling gene chip
  • 相关文献

参考文献2

二级参考文献87

  • 1Parkin DM,Bray F,Ferlay J,Pisani P.Estimating the world cancer burden:Globocan 2000.Int J Cancer 2001; 94:153-156.
  • 2Befeler AS,Di Bisceglie AM.Hepatocellular carcinoma:diagnosis and treatment.Gastroenterology 2002; 122:1609-1619.
  • 3Liu JH,Chen PW,Asch SM,Busuttil RW,Ko CY.Surgery for hepatocellular carcinoma:does it improve survival? Ann Surg Oncol 2004; 11:298-303.
  • 4Fong TL,Kanel GC,Conrad A,Valinluck B,Charboneau F,Adkins RH.Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease.Hepatology 1994; 19:554-557.
  • 5Ming L,Thorgeirsson SS,Gail MH,Lu P,Harris CC,Wang N,Shao Y,Wu Z,Liu G,Wang X,Sun Z.Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong,China.Hepatology 2002; 36:1214-1220.
  • 6Hassan MM,Hwang LY,Hatten CJ,Swaim M,Li D,Abbruzzese JL,Beasley P,Patt YZ.Risk factors for hepatocellular carcinoma:synergism of alcohol with viral hepatitis and diabetes mellitus.Hepatology 2002; 36:1206-1213.
  • 7Ohata K,Hamasaki K,Toriyama K,Matsumoto K,Saeki A,Yanagi K,Abiru S,Nakagawa Y,Shigeno M,Miyazoe S,Ichikawa T,Ishikawa H,Nakao K,Eguchi K.Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.Cancer 2003; 97:3036-3043.
  • 8El-Serag HB,Richardson PA,Everhart JE.The role of diabetes in hepatocellular carcinoma:a case-control study among United States Veterans.Am J Gastroenterol 2001; 96:2462-2467.
  • 9Davila JA,Morgan RO,Shaib Y,McGlynn KA,El-Serag HB.Diabetes increases the risk of hepatocellular carcinoma in the United States:a population based case control study.Gut 2005; 54:533-539.
  • 10Chokshi MM,Marrero JA.Hepatocellular carcinoma.Curr Opin Gastroenterol 2001; 17:276-280.

共引文献54

同被引文献17

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部